http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010151944-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010151944-A |
| titleOfInvention | Niacin and NSAIDs for Combination Therapy |
| abstract | 1. A pharmaceutical composition comprising niacin and aspirin, wherein the total daily dose of aspirin is from about 80 mg to about 500 mg, with aspirin being released from the composition in the range of from about 2 to about 16 hours, and a pharmaceutically acceptable carrier. ! 2. The pharmaceutical composition according to claim 1, in which the total daily dose of aspirin is from about 80 mg to about 320 mg. ! 3. The pharmaceutical composition according to claim 2, in which the total daily dose of aspirin is from about 100 mg to about 140 mg. ! 4. The pharmaceutical composition according to claim 3, in which the total daily dose of aspirin is approximately 120 mg. ! 5. The pharmaceutical composition according to claim 1, in which the total daily dose of aspirin is from about 120 mg to about 240 mg. ! 6. The pharmaceutical composition according to claim 5, in which the total daily dose of aspirin is from about 140 mg to about 200 mg. ! 7. The pharmaceutical composition according to claim 6, in which the total daily dose of aspirin is from about 160 mg to about 162 mg. ! 8. The pharmaceutical composition according to claim 1, in which the total daily dose of aspirin is from about 180 mg to about 300 mg. ! 9. The pharmaceutical composition of claim 8, in which the total daily dose of aspirin is from about 200 mg to about 260 mg. !ten. The pharmaceutical composition of claim 9, wherein the total daily dose of aspirin is from about 240 mg to about 243 mg. ! 11. The pharmaceutical composition according to claim 9, in which the total daily dose of aspirin is approximately 240 mg. ! 12. The pharmaceutical composition according to claim 1, in which the total daily dose of aspirin is from about 200 mg to about |
| priorityDate | 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.